Results of a retrospective study comparing ConforMIS’ (CFMS) custom total knee arthroplasty (TKA) implants vs. standard, off the shelf devices (OTS) indicate a lower number of adverse events, more rapid discharge, lower follow-up care costs, etc. with custom devices.
Per results, TKA patients receiving custom implants:
- experienced fewer adverse events at both discharge and 90 days
- were discharged in less than 3 days to a greater extent
- were discharged to a rehab center or other post-acute care facility to a lesser extent
- required fewer blood transfusions
Additionally, total average real hospital costs between custom and OTS groups were nearly identical (customized $16,192 vs OTS $16,240), and follow-up care costs showed a savings of $1,313 (customized $5,048 vs OTS $6,361).
Results, which were financialy supported by CFMS, were published in Arthroplasty Today.
Source: ConforMIS, Inc.
Results of a retrospective study comparing ConforMIS' (CFMS) custom total knee arthroplasty (TKA) implants vs. standard, off the shelf devices (OTS) indicate a lower number of adverse events, more rapid discharge, lower follow-up care costs, etc. with custom devices.
Per results, TKA patients receiving custom implants:
experienced...
Results of a retrospective study comparing ConforMIS’ (CFMS) custom total knee arthroplasty (TKA) implants vs. standard, off the shelf devices (OTS) indicate a lower number of adverse events, more rapid discharge, lower follow-up care costs, etc. with custom devices.
Per results, TKA patients receiving custom implants:
- experienced fewer adverse events at both discharge and 90 days
- were discharged in less than 3 days to a greater extent
- were discharged to a rehab center or other post-acute care facility to a lesser extent
- required fewer blood transfusions
Additionally, total average real hospital costs between custom and OTS groups were nearly identical (customized $16,192 vs OTS $16,240), and follow-up care costs showed a savings of $1,313 (customized $5,048 vs OTS $6,361).
Results, which were financialy supported by CFMS, were published in Arthroplasty Today.
Source: ConforMIS, Inc.
You’ve reached your limit.
We’re glad you’re finding value in our content — and we’d love for you to keep going.
Subscribe now for unlimited access to orthopedic business intelligence.
JV
Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.





